Original Research
Accepted on 10 Feb 2026
Anjiang Formula Inhibits PVN Microglial Activation and Lowers Blood Pressure by Targeting RhoA/ROCK2 Pathway: A Retrospective Clinical and Experimental Study
in Ethnopharmacology
Original Research
Accepted on 10 Feb 2026
in Ethnopharmacology
Clinical Trial
Accepted on 10 Feb 2026
in Public Health Education and Promotion
Original Research
Accepted on 10 Feb 2026
in Pharmacoepidemiology
Original Research
Accepted on 10 Feb 2026
in Fuel Cells, Electrolyzers and Membrane Reactors
Editorial
Accepted on 10 Feb 2026
in Pharmacogenetics and Pharmacogenomics
Original Research
Accepted on 10 Feb 2026
in Solar Energy
Original Research
Accepted on 10 Feb 2026
in Clinical Diabetes
Original Research
Accepted on 10 Feb 2026
in Mechatronics
Original Research
Accepted on 10 Feb 2026
in Plant Abiotic Stress
Original Research
Accepted on 10 Feb 2026
in Personality Disorders
Methods
Accepted on 10 Feb 2026
in Implementation Science
Original Research
Accepted on 10 Feb 2026
in Clinical Diabetes
Original Research
Accepted on 10 Feb 2026
in Optics and Photonics
Original Research
Accepted on 10 Feb 2026
in Optics and Photonics
Review
Accepted on 10 Feb 2026
in Autoimmune and Autoinflammatory Disorders: Autoinflammatory Disorders
Original Research
Accepted on 10 Feb 2026
in Phage Biology